These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6200330)

  • 1. Determination of human chorionic gonadotrophin (beta subunit) in saliva and its role in trophoblastic diseases.
    Turkes A; Pennington GW; Griffiths K
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):291-2. PubMed ID: 6200330
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated intravesicular fluid thyroid-stimulating hormone concentration in hydatidiform mole.
    Gunasegaram R; Peh KL; Loganath A; Kottegoda SR; Ratnam SS
    Int J Gynaecol Obstet; 1986 Jun; 24(3):177-81. PubMed ID: 2434371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histological prognosis of hydatidiform mole].
    Guillaud-Bourgeois M; Vitrey D
    Arch Anat Cytol Pathol; 1983; 31(3):160-1. PubMed ID: 6193761
    [No Abstract]   [Full Text] [Related]  

  • 4. The level of beta-subunit of human chorionic gonadotrophin in benign hydatidiform mole.
    Tangtakul S; Srisupundit S
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():111-3. PubMed ID: 2458424
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydatidiform moles.
    Heath JM; Bu TH; Brereton WF
    Am Fam Physician; 1985 May; 31(5):123-31. PubMed ID: 2581433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Principles of prophylaxis, early detection, treatment and follow-up of gestational trophoblastic tumors].
    Ebeling K; Sarembe B
    Zentralbl Gynakol; 1988; 110(22):1401-6. PubMed ID: 2464881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCG assays. A plea for uniformity.
    Bock JL
    Am J Clin Pathol; 1990 Mar; 93(3):432-3. PubMed ID: 1689949
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of trophoblastic neoplasms through radioimmunoassay of the urinary carboxy-terminal fragment of beta-choriogonadotropin (COOH-beta-HCG-RIA).
    Ayala AR; González E; Castorena G; de Jesús Montoya J
    Arch Invest Med (Mex); 1984; 15(2):139-45. PubMed ID: 6207791
    [No Abstract]   [Full Text] [Related]  

  • 10. Chorionic gonadotrophin in hydatidiform moles.
    DICZFALUSY E; NILSSON L; WESTMAN A
    Acta Endocrinol (Copenh); 1958 Jun; 28(2):137-47. PubMed ID: 13532387
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
    Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-subunit hCG and the control of trophoblastic disease.
    Zárate A; MacGregor C
    Semin Oncol; 1982 Jun; 9(2):187-90. PubMed ID: 6289461
    [No Abstract]   [Full Text] [Related]  

  • 13. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydatidiform mole and persistent trophoblastic disease in adolescents.
    Parrish SK
    J Pediatr; 1986 Nov; 109(5):838-40. PubMed ID: 2430085
    [No Abstract]   [Full Text] [Related]  

  • 15. Localization of HCG alpha and HCG beta in trophoblastic tumors.
    Kawagoe K; Mori S
    Asia Oceania J Obstet Gynaecol; 1984 Mar; 10(1):111-7. PubMed ID: 6203510
    [No Abstract]   [Full Text] [Related]  

  • 16. CA-125: a marker for persistent gestational trophoblastic disease?
    Koonings PP; Schalerth JB
    Gynecol Oncol; 1993 May; 49(2):240-2. PubMed ID: 7684994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
    Khan S; Katabuchi H; Araki M; Ohba T; Koizumi T; Okamura H; Nishimura R
    Placenta; 2000 Jan; 21(1):79-87. PubMed ID: 10692255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-operative follow-up study of trophoblastic tumors using radioimmunoassay for HCG and LH.
    Chen T
    Acta Obstet Gynaecol Jpn; 1971 Jan; 18(1):13-8. PubMed ID: 4326707
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of the production of chorionic gonadotropin by the cells of trophoblastic tumors (immunohistochemical research)].
    Pozharisskiĭ KM; Zueva EE; Nikitin AIu
    Vopr Onkol; 1988; 34(8):945-51. PubMed ID: 2844022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trophoblastic disease monitoring.
    O'Brien TJ
    Clin Obstet Gynecol; 1984 Mar; 27(1):240-7. PubMed ID: 6200261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.